Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Letter From The Editor Previous | All Articles This Week | Next
This article originally posted 27 July, 2012 and appeared in  Issue 636

Letter from the Editor #636: New Data Points to Impressive CV Effects from GLP-1 Analogs

I want to let all of you know that Steve, Andrew and I will be at the AADE 12 Annual Meeting & Exhibition in Indianapolis this coming week. Please stop by our booth (#526) to pick up some freebies and complete our electronic survey for a chance to win some great prizes.

We have arranged interviews with some of the best presenters at the meeting and for those of you who can't attend, be sure to check out these videos which will be ready in the near future. We are almost done editing the interviews from the AACE and ADA meeting and will be posting them for you in the next couple of weeks.

We have a special feature for you this week from our FAMU PharmD Candidate, Tina Burge, on the cardiovascular effects of GLP-1 analogs and how they can benefit your patient's heart and vascular health. This article is a sneak preview from our special edition, Maximizing the Benefits of GLP-1, coming to your mailbox this weekend.

Be sure to check out Item 11 to find out how a simple device you can wear on your waist can actually double physical activity

*****

Announcements:

dLife.com: July 29, 7PM ET on CNBC

Topics: Guitar rock legend Leslie West shares his struggles with diabetes; dLife profiles world-renowned street artist Shepherd Fairey; and Jim Turner returns with more man on the street interviews. Sundays on CNBC at 7 PM ET, 6 PM CT, and 4 PM PT. Catch up on dLife.com.

TCOYD CME Conference, Missoula, Montana, Saturday, September 8, 2012

The TCOYD Continuing Medical Education Program offers a unique opportunity to bridge patient and professional education, demonstrating the link between clinical lessons in the classroom to the real life patient experience. Find out more here.

Please answer this week's poll: With Belviq and Qsymia now available, will you be more aggressive in treating obesity?

Vote in and then see results from previous polls here.

*****************************
We can make a difference!
*****************************

Check out this week's Test Your Knowledge question.

Dave Joffe, Editor-in-chief 

Advertisement
Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 27 July, 2012 and appeared in  Issue 636

Past five issues: Issue 678 | Diabetes Clinical Mastery Series Issue 137 | Issue 677 | SGLT2 Special Edition Issue 2 | Diabetes Clinical Mastery Series Issue 136 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
Should a person newly diagnosed with prediabetes be treated with medication along with lifestyle changes?

Navigate Diabetes In Control



Search Articles On Diabetes In Control